Nikola Milojević
Croatia
Aesthetic physician, Congress President
Dr Nikola Milojević is the owner and clinical director of Polyclinic Milojević, which is one of Croatia's leading aesthetic medicine clinics, specialising in the whole range of aesthetic procedures and treatments for the face and body. Polyclinic Milojević was the first clinic in Croatia and the wider region to specialise purely in aesthetic medicine. Poliklinika Milojevic is always at the forefront of innovations in aesthetic medicine, and can now boast about the most comprehensive laser and light centre for the face and body, with over 30 different devices.
In Croatia, Dr. Milojević is regarded as the leading aesthetic medicine doctor, a key opinion leader, a lecturer and an expert trainer.
Dr. Nikola Milojević was exposed to the world of aesthetic medicine from a very early age. His father, Professor Boško Milojević was one of the European pioneers of modern plastic surgery. He opened the first private aesthetic surgery clinic in 1967 in the capital of Croatia, Zagreb, which was the first such clinic in the region.
Dr Milojević studied for his medical degree at The Royal Free Hospital School of Medicine in London from 1990-1995. London was where Dr Milojević started his career in aesthetic medicine and was among the first doctors in the UK to start applying botox and dermal fillers and to start developing advanced techniques such as non-surgical eye-bag removal and nose shaping using dermal fillers. He was one of the earliest members of the British College of Aesthetic Medicine (BCAM).
He performs as many as 30-40 botox, dermal filler and laser procedures per day, and during his career, he has performed over 60,000 cases of dermal filler, botox and other aesthetic treatments.
Dr. Milojevic is the founder and president of the TAMC Congress, which is fast becoming one of the best-regarded aesthetic congresses in Europe, and his ambition is to continue to further the borders of aesthetic education through the TAMC Congress and TAMC academy for many years to come.